Biobanking Market Report 2025-2035

The Biobanking Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Accelerated Market Growth Driven by Multi-Omics and AI Integration

The global biobanking market-valued at US$83.1 billion in 2025 and projected to reach US$194.0 billion by 2035 is accelerating as the sector transitions from conventional sample storage to large-scale, data-rich, multi-omics and AI-enabled research infrastructure. Historically centred on limited academic repositories, biobanks have evolved into globally interconnected platforms managing millions of high-quality samples linked to clinical, genomic, and proteomic datasets. This transformation reflects a broader industry shift toward the active utilisation of biospecimens in sequencing, biomarker discovery, drug development, and translational medicine. Large national and institutional initiatives-such as advanced proteomic mapping involving hundreds of thousands of samples demonstrate the sector's expanding role. Notably, on 13 January 2025, Illumina announced a pilot proteomics programme analysing 50,000 UK Biobank samples alongside deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis, leveraging its next-generation Illumina Protein Prep‚Ñ¢ platform. Such collaborations highlight how modern biobanks are becoming critical engines for precision medicine, disease-risk analysis, and long-term population health research, driving robust market expansion.

What would be the Impact of US Trade Tariffs on the Global Biobanking Market?

U.S. trade tariffs are exerting upward pressure on cost structures across the biobanking value chain, particularly for imported ultra-low-temperature freezers, cryogenic systems, automation modules, consumables, and LIMS-related hardware. These cost increases are prompting biobanks to reassess procurement and shift toward regional or tariff-exempt suppliers to maintain budget stability. The tariffs are also slowing infrastructure upgrades, delaying expansion timelines, and constraining capital allocation for advanced automation and digitalisation projects. In response, global suppliers are restructuring manufacturing footprints, while service providers adjust pricing for storage and processing to offset rising costs. Overall, the tariff environment is accelerating trends toward localisation, multi-vendor sourcing, and financially disciplined operational planning across the biobanking sector.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Biobanking market evolving?
• What is driving and restraining the Biobanking market?
• How will each Biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
• How will the market shares for each Biobanking submarket develop from 2025 to 2035?
• What will be the main driver for the overall market from 2025 to 2035?
• Will leading Biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Biobanking projects for these leading companies?
• How will the industry evolve during the period between 2025 and 2035? What are the implications of
• Biobanking projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Biobanking market?
• Where is the Biobanking market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Biobanking market today, and over the next 10 years:

• Our 355-page report provides 121 tables and 182 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them - NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Products and Services

• Equipment - Storage Equipment - Sample Analysis Equipment - Sample Processing Equipment - Sample Transport Equipment
• Consumables - Storage Consumables - Analysis Consumables - Processing Consumables - Collection Consumables
• Services - Storage Services - Processing Services - Transport Services - Supply Services Software

Storage Type

• Automated Storage
• Manual Storage

Ownership

• National/Regional Agencies
• Universities
• Non-profit
• Private

Sample

• Blood Products
• Human Tissues
• Nucleic Acids
• Cell Lines
• Biological Fluids

Application

• Regenerative Medicine
• Life Science Research
• Clinical Research

End-users

• Pharmaceutical & Biotechnology Companies
• CROs
• Academic & Research Institutes
• Hospitals

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Switzerland
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2025 to 2035, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

• ASKION GmbH
• Avantor, Inc.
• Azenta Inc.
• BD
• BioIVT
• Boca Biolistics
• Charles River Laboratories International, Inc.
• Cryoport, Inc.
• CTIBiotech
• Hamilton Company
• ISENET
• Labcorp
• Merck KGaA
• PHC Holdings Corporation
• ProteoGenex Inc.
• QIAGEN
• SciSafe
• STEMCELL Technologies
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• US Biolab Corporation

Overall world revenue for Biobanking Market, 2025 to 2035 in terms of value the market will surpass US$80.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biobanking Market, 2025 to 2035 report help you?

In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2035 for Biobanking Market 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 26 key national markets - See forecasts for the Biobanking Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 22 of the major companies involved in the Biobanking Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biobanking Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment. Show more